P2RY2 and neoplasm: This data suggests (1) the lower limits of the technique compounded by the challenge of RNA degradation in pancreatic tissue and (2) supports that in tumor tissue where it was detected there was indeed overexpression of P2Y2, in line with the bioinformatic data.